Sarepta Therapeutics, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 01:30:00 22/07/2026 am IST			After hours 05:28:01 am
16.21 ^USD	-3.68%		16.98	+4.75%

30/06	Sarepta Therapeutics Announces FDA Acceptance Of Supplemental New Drug Applications For Amondys 45 And Vyondys 53 For Duchenne Muscular Dystrophy	CI
30/06	Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications	MT

Published on 06/04/2026 at 09:05 pm IST

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Hello, and welcome to the Annual Meeting of Stockholders of Sarepta Therapeutics, Inc. Please note that today's meeting is being recorded.

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

30/06	Sarepta Therapeutics Announces FDA Acceptance Of Supplemental New Drug Applications For Amondys 45 And Vyondys 53 For Duchenne Muscular Dystrophy	CI
30/06	Sarepta Therapeutics Gets FDA Review for Duchenne Muscular Dystrophy Applications	MT
30/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell 1000 Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to Russell 2000 Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell Midcap Growth Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to Russell 2000 Value Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to Russell 2000 Growth Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell 1000 Growth Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell 1000 Dynamic Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) added to Russell 2000 Dynamic Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell Midcap Value Benchmark	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell Midcap Index	CI
29/06	Sarepta Therapeutics, Inc.(NasdaqGS:SRPT) dropped from Russell 1000 Value Benchmark	CI
18/06	Sarepta's Elevidys Showing Signs of Stabilization as siRNA Pipeline Gains Importance, RBC Says	MT
08/06	Sarepta Therapeutics, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-08-2026 10:40 AM